Asthma Link for Childhood Asthma
Trial Summary
The trial does not specify if you need to stop taking your current medications. However, since children must be prescribed a daily inhaled corticosteroid (ICS) for asthma to participate, it seems likely that they will continue with this medication during the trial.
Research shows that school-supervised asthma therapy, like Asthma Link, improves medication adherence and health outcomes for children with asthma. Programs that involve schools, families, and healthcare providers have been successful in managing asthma and reducing school absences due to asthma symptoms.
12345The Asthma Link program, which involves school-supervised asthma therapy, has been shown to improve health outcomes for children with asthma, but the available research does not specifically address safety concerns. It focuses on improving asthma management and coordination among schools, families, and healthcare providers.
12356Asthma Link is unique because it involves school-supervised therapy, where children receive their asthma medication at school, improving adherence and health outcomes. This approach is designed to be sustainable and low-cost, making it easier to adopt in real-world settings compared to traditional home-based treatments.
12678Eligibility Criteria
This trial is for children aged 5-14 with poorly controlled asthma. It's designed to see if a school program called Asthma Link can help manage their symptoms better than an educational workbook.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Children receive school-supervised asthma therapy or an educational asthma workbook
Follow-up
Participants are monitored for asthma control and medication adherence
Participant Groups
Asthma Link is already approved in United States for the following indications:
- Poorly controlled asthma in children aged 5-14